These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 16989778

  • 1. Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis.
    Himmerich H, Binder EB, Künzel HE, Schuld A, Lucae S, Uhr M, Pollmächer T, Holsboer F, Ising M.
    Biol Psychiatry; 2006 Oct 15; 60(8):882-8. PubMed ID: 16989778
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S.
    Neuropsychopharmacology; 2003 Dec 15; 28(12):2169-78. PubMed ID: 12931142
    [Abstract] [Full Text] [Related]

  • 3. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan 15; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 4. Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment.
    Himmerich H, Zimmermann P, Ising M, Kloiber S, Lucae S, Kunzel HE, Binder EB, Holsboer F, Uhr M.
    Neuropsychobiology; 2007 Jan 15; 55(1):28-35. PubMed ID: 17556850
    [Abstract] [Full Text] [Related]

  • 5. Effects of dexamethasone on cytokine plasma levels and white blood cell counts in depressed patients.
    Schuld A, Kraus T, Haack M, Hinze-Selch D, Zobel AW, Holsboer F, Pollmächer T.
    Psychoneuroendocrinology; 2001 Jan 15; 26(1):65-76. PubMed ID: 11070335
    [Abstract] [Full Text] [Related]

  • 6. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
    Kunugi H, Ida I, Owashi T, Kimura M, Inoue Y, Nakagawa S, Yabana T, Urushibara T, Kanai R, Aihara M, Yuuki N, Otsubo T, Oshima A, Kudo K, Inoue T, Kitaichi Y, Shirakawa O, Isogawa K, Nagayama H, Kamijima K, Nanko S, Kanba S, Higuchi T, Mikuni M.
    Neuropsychopharmacology; 2006 Jan 15; 31(1):212-20. PubMed ID: 16123748
    [Abstract] [Full Text] [Related]

  • 7. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
    Schüle C, Baghai TC, Eser D, Zwanzger P, Jordan M, Buechs R, Rupprecht R.
    Psychopharmacology (Berl); 2006 Jul 15; 186(4):601-11. PubMed ID: 16758243
    [Abstract] [Full Text] [Related]

  • 8. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    Psychoneuroendocrinology; 2008 Feb 15; 33(2):152-61. PubMed ID: 18068306
    [Abstract] [Full Text] [Related]

  • 9. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, Heijnen C, Westenberg H.
    Psychoneuroendocrinology; 2008 Apr 15; 33(3):313-20. PubMed ID: 18215470
    [Abstract] [Full Text] [Related]

  • 10. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N, Künzel HE, Pfennig A, Uhr M, Holsboer F.
    Biol Psychiatry; 2007 Jul 01; 62(1):47-54. PubMed ID: 17123470
    [Abstract] [Full Text] [Related]

  • 11. Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus.
    Felger JC, Haroon E, Woolwine BJ, Raison CL, Miller AH.
    Physiol Behav; 2016 Nov 01; 166():14-21. PubMed ID: 26703235
    [Abstract] [Full Text] [Related]

  • 12. Neuroendocrinological mechanisms of actions of antidepressant drugs.
    Schüle C.
    J Neuroendocrinol; 2007 Mar 01; 19(3):213-26. PubMed ID: 17280595
    [Abstract] [Full Text] [Related]

  • 13. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E.
    Psychoneuroendocrinology; 2004 Oct 01; 29(9):1101-8. PubMed ID: 15219633
    [Abstract] [Full Text] [Related]

  • 14. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M.
    J Psychiatr Res; 2008 Oct 01; 42(14):1154-62. PubMed ID: 18281062
    [Abstract] [Full Text] [Related]

  • 15. Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action.
    Horstmann S, Dose T, Lucae S, Kloiber S, Menke A, Hennings J, Spieler D, Uhr M, Holsboer F, Ising M.
    Psychoneuroendocrinology; 2009 Feb 01; 34(2):238-248. PubMed ID: 18926641
    [Abstract] [Full Text] [Related]

  • 16. Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients.
    Schüle C, Zill P, Baghai TC, Eser D, Zwanzger P, Wenig N, Rupprecht R, Bondy B.
    Psychoneuroendocrinology; 2006 Sep 01; 31(8):1019-25. PubMed ID: 16890377
    [Abstract] [Full Text] [Related]

  • 17. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior.
    Sher L.
    ScientificWorldJournal; 2006 Oct 31; 6():1398-404. PubMed ID: 17086345
    [Abstract] [Full Text] [Related]

  • 18. PCLO rs2522833 modulates HPA system response to antidepressant treatment in major depressive disorder.
    Schuhmacher A, Mössner R, Höfels S, Pfeiffer U, Guttenthaler V, Wagner M, Schwab SG, Maier W, Zobel A.
    Int J Neuropsychopharmacol; 2011 Mar 31; 14(2):237-45. PubMed ID: 20701824
    [Abstract] [Full Text] [Related]

  • 19. HPA axis normalization, estimated by DEX/CRH test, but less alteration on cerebral glucose metabolism in depressed patients receiving ECT after medication treatment failures.
    Yuuki N, Ida I, Oshima A, Kumano H, Takahashi K, Fukuda M, Oriuchi N, Endo K, Matsuda H, Mikuni M.
    Acta Psychiatr Scand; 2005 Oct 31; 112(4):257-65. PubMed ID: 16156832
    [Abstract] [Full Text] [Related]

  • 20. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR.
    Psychoneuroendocrinology; 2012 Aug 31; 37(8):1199-208. PubMed ID: 22277728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.